- Home
- HOLX
HOLX
Hologic Inc.
as 10-17-2024 4:00pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 18.9B | IPO Year: | 1990 |
| Target Price: | $87.50 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.92 | EPS Growth: | 49.92 |
| 52 Week Low/High: | $64.02 - $84.67 | Next Earning Date: | 11-04-2024 |
| Revenue: | $3,987,600,000 | Revenue Growth: | -1.26% |
| Revenue Growth (this year): | 1.73% | Revenue Growth (next year): | 5.27% |
Stock Insider Trading Activity of Hologic Inc. (HOLX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Oberton Karleen Marie | HOLX | Chief Financial Officer | Aug 29 '24 | Sell | $80.56 | 52,679 | $4,243,662.20 | 84,042 | |
| Schnittker Brandon | HOLX | Div. President, GYN Surgical | Aug 6 '24 | Sell | $83.11 | 476 | $39,559.41 | 3,735 | |
| COHN BENJAMIN JORDAN | HOLX | Principal Accounting Officer | Aug 1 '24 | Sell | $81.99 | 5,093 | $417,569.98 | 10,476 | |
| MACMILLAN STEPHEN P | HOLX | Chairman, President and CEO | Jul 30 '24 | Sell | $81.45 | 44,039 | $3,597,924.24 | 1,193,967 |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Hologic (HOLX) Gains As Market Dips: What You Should Know
MedTech Dive
3 days ago
Hologic to buy Gynesonics for $350M to acquire fibroid system
Medical Device Network
3 days ago
Hologic to acquire Gynesonics to strengthen women’s health portfolio
Benzinga
3 days ago
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
MT Newswires
3 days ago
JPMorgan Adjusts Hologic Price Target to $92 From $95, Maintains Overweight Rating
MT Newswires
4 days ago
Hologic to Acquire Gynesonics for About $350 Million
Business Wire
4 days ago
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
Simply Wall St.
6 days ago
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Compare HOLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.